Scholarly publications and presentations by Rochester Regional Health's Oncology and Hematology department authors.
Submissions from 2026
6-17-2026 The Goldilocks Guide to Breast Cancer: Not too Much, Not too Little, Just Right, Rachel David, Rochester Regional Health and Vatsala Kirtani, Rochester Regional Health
6-1-2026 Association between chemotherapy-induced neuropathy and gabapentin exposure among adults receiving chemotherapy: A National Inpatient Sample study (2017-2021), Mahima Shenoi, Rochester Regional Health, Purva Shah, Rochester Regional Health, Candrika D. Khairani, Rochester Regional Health, et al.
6-1-2026 Association between gabapentinoid exposure and chemotherapy-associated peripheral neuropathy among adults starting new neurotoxic chemotherapy in a multi-hospital health system, Candrika D. Khairani, Rochester Regional Health, Mahima Shenoi, Rochester Regional Health, Purva Shah, Rochester Regional Health, et al.
6-1-2026 Association between palliative care consultation and end-of-life care intensity in multiple myeloma, Muhammad Haseeb Khan, Rochester Regional Health, Rabbia Irfan, Nimra Niaz, et al.
6-1-2026 Breast cancer screening is heating up: A novel thermophysics-based AI modality for screening subjects with BIRADS 4 or 5 mammograms, Nedal Darwish, Rochester Regional Health, Jessica Arconti Fleming, Rochester Regional Health, Carlos Gutierrez, et al.
5-27-2026 Medical Aid in Dying: History, New York's New Law, Your Responsibilities, and the Science, Brieze K. Bell, University of California, San Francisco; C Chris Reynolds, Rochester Regional Health; Lonny Shavelson, Academy of Aid-in-Dying Medicine; and Kayla St. Lucia, Rochester Regional Health
5-1-2026 PP01.138: Real-World Effectiveness and Safety of Lurbinectedin for Small Cell Lung Cancer (SCLC): Updates From Jazz EMERGE 402, Firas Badin, Philip Lammers, Geoffrey Liu, et al.
4-1-2026 429P Real-world (RW) effectiveness and safety of lurbinectedin for previously treated small cell lung cancer (SCLC): Jazz EMERGE 402, B Halmos, P Lammers, G Liu, et al.
4-1-2026 Antifibrinolytics, Amir A. Mahmoud and Peter A. Kouides, Rochester Regional Health
4-1-2026 Antiplatelet Agents, Amir A. Mahmoud and Peter A. Kouides, Rochester Regional Health
4-1-2026 Secondary Hemophagocytic Lymphohistiocytosis as the Initial Presentation of Metastatic Carcinoma of Likely Colorectal Origin, Kavya Balusu, Rochester Regional Health, Ali Abdelhay, Rochester Regional Health, Kim Sung Eun, Rochester Regional Health, et al.
4-1-2026 Unprovoked Venous Thromboembolism in a Patient with a Small PNH Clone: A Therapeutic Dilemma, Kavya Balusu, Rochester Regional Health; Dhatri Malipeddi, Rochester Regional Health; and Pradyumna Phatak, Rochester Regional Health
4-1-2026 von Willebrand Disease: Management, Mouhamed Yazan Abou-Ismail and Peter A. Kouides, Rochester Regional Health
3-18-2026 Beyond the Tumor: Addressing Total Pain in Triple Negative Breast Cancer Through Interdisciplinary Palliative Care, Etta Eskridge, Rochester Regional Health and Kayla St. Lucia, Rochester Regional Health
3-1-2026 Impact of Optimizing the Lower Limit of Normal for Ferritin on Iron Deficiency Diagnosis and Treatment Patterns: A Pre and Post-Intervention Study Using EHR Data, Ali Abdelhay, Rochester Regional Health, Mouna Reghis, Rochester Regional Health, Tamer Salhab Altamimi, Rochester Regional Health, et al.
3-1-2026 Papillary immature metaplasia (immature condyloma) of the uterine cervix: A report of three cases in postmenopausal women and review of the literature, Jiqing Ye, Rochester Regional Health, Layla Hatem, Rochester Regional Health, Fadi Hatem, Rochester Regional Health, et al.
2-1-2026 Increase in Hospice Agency Providers as Primary Hospice Attending: A Five-Year Retrospective Chart Review, Mary Onderdonk, Rochester Regional Health; Adam Herman, Rochester Regional Health; and Erin Klinkman, Rochester Regional Health
1-12-2026 Comparative safety of futibatinib vs pemigatinib in metastatic cholangiocarcinoma: FAERS-based analysis, Ajinkya Buradkar, Dhatri Malipeddi, Rochester Regional Health, Zunairah Shah, et al.
Submissions from 2025
12-14-2025 Severe trastuzumab-induced pneumonitis refractory to steroid therapy, Dua Azim, Rochester Regional Health, Aditya Sanjeevi, Rochester Regional Health, Daniel Idoate Domench, Rochester Regional Health, et al.
12-10-2025 Emerging Therapies for Diffuse Large B-Cell Lymphoma, Joseph DiTursi, Rochester Regional Health
11-3-2025 External validation of TTP-14: A novel machine learning model that improves rapid diagnosis of immune TTP, Mouhamed Yazan Abou-Ismail, Meera Sridharan, Chong Zhang, et al.
11-3-2025 Hypogammaglobulinemia in CLL: Analysis of clinical and laboratory correlates, Hassan Saeed, Rochester Regional Health, Syed Usman Mohsin Ehsanullah, Rochester Regional Health, Mouna Reghis, Rochester Regional Health, et al.
11-3-2025 Impact of optimizing the serum ferritin threshold for diagnosis of iron deficiency: A pre- and post-intervention study using EHR data, Mouna Reghis, Rochester Regional Health, Ali Abdelhay, Rochester Regional Health, Tamer Salhab Altamimi, Rochester Regional Health, et al.
11-3-2025 Improved outcome of patients with acute myeloid leukemia treated by a dedicated leukemia service in a community hospital, Maria Sbenghe, Rochester Regional Health, Margaret Schuyler, Rochester Regional Health, Julia Wuest, Rochester Regional Health, et al.
11-3-2025 Influenza as a less commonly recognized cause of hemophagocytic lymphohistiocytosis: A systematic review of case reports and case series, Kavya Balusu, Rochester Regional Health; Ali Abdelhay; and Peter A. Kouides, Rochester Regional Health